Early completion based on multiple dosages to accelerate maximum tolerated dose-finding. (arXiv:2110.00563v1 [q-bio.QM]) http://arxiv.org/abs/2110.00563
CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.